Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
CITIC SEC: After the December Federal Reserve interest rate meeting, the US stock market is expected to regain its upward trend.
JinFu Technology (003018.SZ) plans to acquire at least 51% of the equity of Lan Yuan Technology.
Shenzhen Zhongjin Lingnan Nonfemet (000060.SZ) acquires the minority shareholder equity in its holding subsidiary.
CITIC SEC: After the December Federal Reserve interest rate meeting, the US stock market is expected to regain its upward trend.
JinFu Technology (003018.SZ) plans to acquire at least 51% of the equity of Lan Yuan Technology.
Shenzhen Zhongjin Lingnan Nonfemet (000060.SZ) acquires the minority shareholder equity in its holding subsidiary.
